Zeliweger Syndrome in Saudi Arabia and Its Distinct Features

Abstract

Clinical and laboratory findings of Zellweger syndrome (ZS) patients diagnosed at King Faisal Specialist Hospital and Research Center (KFSH & RC), Riyadh, Saudi Arabia over a period of 10 years are presented in this report. Eleven patients (nine females and two males) from 2 to 4 months old were referred to KFSH & RC for evaluation of hypotonia, seizures, and dysmorphic features. The common clinical findings included high forehead, large fontanelle, shallow orbit ridges, micrognathia, upslanting palebral fissures, epicanthal folds, severe hypotonia, hyporeflexia, pigmentary retinopathy, optic nerve atrophy, complete or partial agenesis of corpus callusum, and failure to thrive. We did not observe any Brushfield spots, any renal and brain cysts, or adrenal insufficiency. Some unique clinical findings were the presence of gallstones, club feet, or bilateral knee or hip dislocation in some patients. All patients had markedly elevated plasma levels of very long chain fatty acids (VLCFA). Electron microscopy performed on liver biopsies of two patients revealed absence of peroxisomes. Biochemical studies of dermal fibroblasts from three patients showed deficient 13-oxidation of lignoceric acid and dihydroxyacetone phosphate acyltransferase (DHAPATase) activity. The tribal living in Saudi Arabia and our observation that 10 of the 11 parents in this study were first-degree relatives and, except for families 1 and 3, each family had at least another baby who died of the same disease. This suggests that the incidence of ZS in Saudi Arabia may actually be higher than our experience at KFSH & RC.

Get full access to this article

View all access options for this article.

References

1. Lazarow PB , Moser HW Disorders of peroxisome biogenesis. In: Scriver CR , Beaudet AL , Sly WS , Valle D , eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. New York: McGraw Hill, 1995:2287-2324.

2. Wilson GN , Holmes RG , Custer J , et al. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. Am JMed Genet. 1986; 24:69-82.

3. Singh I , Moser AE , Goldfischer S , Moser HW Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy. Proc Natl Acad Sci USA. 1984; 81:4203-4207.

4. Hajra AK , Bushop JE Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann N Y Acad Sci. 1982; 386: 170-182.

5. Goldfischer S , Moore CL , Johnson A , et al. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science. 1973;182:62-64.

6. Kelley RI Review: the cerebrohepatorenal syndrome of Zellweger, morphologic and metabolic aspects. Am J Med Genet. 1983;16:503-517.

7. Govaerts L , Monnens L , Tegelaers W , et al. Cerebro-hepato-renal syndrome of Zellweger: clinical symptoms and relevant laboratory findings in 16 patients. Eur J Pediatr. 1982;139:125-128.

8. Schutgens RB , Heymans HS , Wanders RJ , et al. Peroxisomal disorders: a newly recognized group of genetic diseases. Eur J Pediatr. 1986;144:430-440.

9. Bowen P , Lee CSN , Zellweger H , Lindberg R . A familial syndrome of multiple congenital defects. Bull John Hopkins Hosp. 1964;114:402-414.

10.

10. Caruso U , Fowler B , Erceg M , Romano C . Determination of very-long-chain fatty acids in plasma by a simplified gas chromatographic-mass spectrometric procedure. J Chromatograph. 1991;562:147-152.

11.

11. Vallance H , Applegarth D . An improved method for the quantification of very long chain fatty acids in plasma. Clin Biochem. 1994;27:183-186.

12.

12. Hashmi M , Stanley W , Singh I . Fatty acid metabolism in cultured skin fibroblasts from patients with peroxisomal disorders: lignoceryl-CoA ligase deficiency in childhood adrenoleukodystrophy. Fahimi HD , Seis H , eds. In: Peroxisomes in Medicine and Biology. Springer-Verlag, Heidelberg, 1987; 358-363.

13.

13. Heymans HS. Cerebro-hepato-renal (Zellweger) syndrome. Clinical and biochemical consequences of peroxisomal dysfunction. Thesis. University of Amsterdam, 1984.

14.

14. Poznanski AK , Nosanchuck JS , Baublis J , Holt JF The cerebro-hepato-renal syndrome (CHRS) (Zellweger syndrome). Am JRadiol. 1970;109:313-322.

15.

15. Brown FR III , Voigt R , Singh AK , Singh I . Peroxisomal disorders. Neurodevelopmental and biochemical aspects. Am JDis Child. 1993;147 617-626.

16.

16. Schrakamp G , Roosenboom CF , Schutgens RB , et al. Alkyl dihydroxy-acetone phosphate synthase in human fibroblasts and its deficiency in Zellweger syndrome. J Lip Res. 1985; 26:867-873.

17.

17. Wanders RJ , Smit W , Heymans HS , et al. Age-related accumulation of phytanic acid in plasma from patients with the cerebro-hepato-renal (Zell-weger) syndrome. Clin Chim Acta. 1987;166:45-56.

18.

18. Singh I , Moser HW , Moser AB , Kishimoto Y . Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts and adrenal cortex. Biochem Biophys Res Comm. 1981;102:1223-1229.

19.

19. Rocchiccioli F , Aubourg P , Choiset A . Immediate prenatal diagnosis of Zellweger syndrome by direct measurement of very long chain fatty acids in chorionic villus cells. Prenat Diag. 1987;7:349-354.

20.

20. Heymans HS , Schutgens RB , Tan R , et al. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome). Nature.1983; 306:69-70.

21.

21. Datta NS , Wilson GN , Hajra AK Deficiency of enzymes catalyzing the Biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes. N Engl J Med. 1984;311:1080-1083.